154 related articles for article (PubMed ID: 7773294)
1. A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice.
Harvey M; Vogel H; Morris D; Bradley A; Bernstein A; Donehower LA
Nat Genet; 1995 Mar; 9(3):305-11. PubMed ID: 7773294
[TBL] [Abstract][Full Text] [Related]
2. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
Donehower LA; Harvey M; Slagle BL; McArthur MJ; Montgomery CA; Butel JS; Bradley A
Nature; 1992 Mar; 356(6366):215-21. PubMed ID: 1552940
[TBL] [Abstract][Full Text] [Related]
3. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.
Blyth K; Terry A; O'Hara M; Baxter EW; Campbell M; Stewart M; Donehower LA; Onions DE; Neil JC; Cameron ER
Oncogene; 1995 May; 10(9):1717-23. PubMed ID: 7753548
[TBL] [Abstract][Full Text] [Related]
4. [Generation and analyses of transgenic mice containing mutant p53 transgene].
Hosokawa A
Fukuoka Igaku Zasshi; 1999 Mar; 90(3):80-7. PubMed ID: 10339928
[TBL] [Abstract][Full Text] [Related]
5. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
Wang Y; Zhang Z; Kastens E; Lubet RA; You M
Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
[TBL] [Abstract][Full Text] [Related]
6. p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain.
Nishino H; Knöll A; Buettner VL; Frisk CS; Maruta Y; Haavik J; Sommer SS
Oncogene; 1995 Jul; 11(2):263-70. PubMed ID: 7624143
[TBL] [Abstract][Full Text] [Related]
7. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
8. Long-term infection with Helicobacter felis and inactivation of the tumour suppressor gene p53 cumulatively enhance the gastric mutation frequency in Big Blue transgenic mice.
Jenks PJ; Jeremy AH; Robinson PA; Walker MM; Crabtree JE
J Pathol; 2003 Dec; 201(4):596-602. PubMed ID: 14648663
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
Harvey M; McArthur MJ; Montgomery CA; Butel JS; Bradley A; Donehower LA
Nat Genet; 1993 Nov; 5(3):225-9. PubMed ID: 8275085
[TBL] [Abstract][Full Text] [Related]
10. p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis.
Gao J; Huang HY; Pak J; Cheng J; Zhang ZT; Shapiro E; Pellicer A; Sun TT; Wu XR
Oncogene; 2004 Jan; 23(3):687-96. PubMed ID: 14737103
[TBL] [Abstract][Full Text] [Related]
11. p53 protects against skin cancer induction by UV-B radiation.
Jiang W; Ananthaswamy HN; Muller HK; Kripke ML
Oncogene; 1999 Jul; 18(29):4247-53. PubMed ID: 10435637
[TBL] [Abstract][Full Text] [Related]
12. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke.
De Flora S; Balansky RM; D'Agostini F; Izzotti A; Camoirano A; Bennicelli C; Zhang Z; Wang Y; Lubet RA; You M
Cancer Res; 2003 Feb; 63(4):793-800. PubMed ID: 12591728
[TBL] [Abstract][Full Text] [Related]
13. The mouse equivalent of the human p53ser249 mutation p53ser246 enhances aflatoxin hepatocarcinogenesis in hepatitis B surface antigen transgenic and p53 heterozygous null mice.
Ghebranious N; Sell S
Hepatology; 1998 Apr; 27(4):967-73. PubMed ID: 9537435
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
[TBL] [Abstract][Full Text] [Related]
15. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of potential human carcinogens using B6.129tm1Trp53 heterozygous null mice and loss of heterozygosity at the Trp53 locus.
French JE
IARC Sci Publ; 2004; (157):271-87. PubMed ID: 15055301
[TBL] [Abstract][Full Text] [Related]
17. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
18. Lim2(To3) transgenic mice establish a causative relationship between the mutation identified in the lim2 gene and cataractogenesis in the To3 mouse mutant.
Steele EC; Wang JH; Lo WK; Saperstein DA; Li X; Church RL
Mol Vis; 2000 Jun; 6():85-94. PubMed ID: 10851259
[TBL] [Abstract][Full Text] [Related]
19. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice.
Harvey M; Sands AT; Weiss RS; Hegi ME; Wiseman RW; Pantazis P; Giovanella BC; Tainsky MA; Bradley A; Donehower LA
Oncogene; 1993 Sep; 8(9):2457-67. PubMed ID: 8103211
[TBL] [Abstract][Full Text] [Related]
20. Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis.
Jones JM; Attardi L; Godley LA; Laucirica R; Medina D; Jacks T; Varmus HE; Donehower LA
Cell Growth Differ; 1997 Aug; 8(8):829-38. PubMed ID: 9269892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
